169 related articles for article (PubMed ID: 36330617)
1. Predicting Potential SARS-COV-2 Drugs-In Depth Drug Database Screening Using Deep Neural Network Framework SSnet, Classical Virtual Screening and Docking.
Karki N; Verma N; Trozzi F; Tao P; Kraka E; Zoltowski B
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33557253
[TBL] [Abstract][Full Text] [Related]
2. Exploring Binding Pockets in the Conformational States of the SARS-CoV-2 Spike Trimers for the Screening of Allosteric Inhibitors Using Molecular Simulations and Ensemble-Based Ligand Docking.
Gupta G; Verkhivker G
Int J Mol Sci; 2024 May; 25(9):. PubMed ID: 38732174
[TBL] [Abstract][Full Text] [Related]
3. Structural, dynamic behaviour, in-vitro and computational investigations of Schiff's bases of 1,3-diphenyl urea derivatives against SARS-CoV-2 spike protein.
Ullah S; Ullah A; Waqas M; Halim SA; Pasha AR; Shafiq Z; Mali SN; Jawarkar RD; Khan A; Khalid A; Abdalla AN; Kashtoh H; Al-Harrasi A
Sci Rep; 2024 Jun; 14(1):12588. PubMed ID: 38822113
[TBL] [Abstract][Full Text] [Related]
4. Computational and experimental validation of phthalocyanine and hypericin as effective SARS-CoV-2 fusion inhibitors.
Romeo A; Cappelli G; Iacovelli F; Colizzi V; Falconi M
J Biomol Struct Dyn; 2024 May; 42(8):3920-3934. PubMed ID: 37235773
[TBL] [Abstract][Full Text] [Related]
5. The Discovery of inhibitors of the SARS-CoV-2 S protein through computational drug repurposing.
Avilés-Alía AI; Zulaica J; Perez JJ; Rubio-Martínez J; Geller R; Granadino-Roldán JM
Comput Biol Med; 2024 Mar; 171():108163. PubMed ID: 38417382
[TBL] [Abstract][Full Text] [Related]
6. An Overview of SARS-CoV-2 Potential Targets, Inhibitors, and Computational Insights to Enrich the Promising Treatment Strategies.
Kumawat P; Agarwal LK; Sharma K
Curr Microbiol; 2024 May; 81(7):169. PubMed ID: 38733424
[TBL] [Abstract][Full Text] [Related]
7. Combined in silico strategy for repurposing DrugBank entries towards introducing potential anti-SARS-CoV-2 drugs.
Ghavami G; Adibzadeh S; Amiri S; Sardari S
Can J Physiol Pharmacol; 2023 Jun; 101(6):268-285. PubMed ID: 36848647
[TBL] [Abstract][Full Text] [Related]
8. The Dual-Targeted Fusion Inhibitor Clofazimine Binds to the S2 Segment of the SARS-CoV-2 Spike Protein.
Freidel MR; Vakhariya PA; Sardarni SK; Armen RS
Viruses; 2024 Apr; 16(4):. PubMed ID: 38675980
[TBL] [Abstract][Full Text] [Related]
9. Pseudovirus-Based Systems for Screening Natural Antiviral Agents: A Comprehensive Review.
Trischitta P; Tamburello MP; Venuti A; Pennisi R
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791226
[TBL] [Abstract][Full Text] [Related]
10. Colloidal Aggregation Confounds Cell-Based Covid-19 Antiviral Screens.
Glenn IS; Hall LN; Khalid MM; Ott M; Shoichet BK
J Med Chem; 2024 Jun; 67(12):10263-10274. PubMed ID: 38864383
[TBL] [Abstract][Full Text] [Related]
11. Repositioning microbial biotechnology against COVID-19: the case of microbial production of flavonoids.
Goris T; Pérez-Valero Á; Martínez I; Yi D; Fernández-Calleja L; San León D; Bornscheuer UT; Magadán-Corpas P; Lombó F; Nogales J
Microb Biotechnol; 2021 Jan; 14(1):94-110. PubMed ID: 33047877
[TBL] [Abstract][Full Text] [Related]
12. K
Das P; Mazumder DH
Comput Biol Chem; 2024 Jun; 110():108066. PubMed ID: 38579549
[TBL] [Abstract][Full Text] [Related]
13. Drug Repositioning Using Computer-aided Drug Design (CADD).
Rawat S; Subramaniam K; Subramanian SK; Subbarayan S; Dhanabalan S; Chidambaram SKM; Stalin B; Roy A; Nagaprasad N; Aruna M; Tesfaye JL; Badassa B; Krishnaraj R
Curr Pharm Biotechnol; 2024; 25(3):301-312. PubMed ID: 37605405
[TBL] [Abstract][Full Text] [Related]
14. Colloidal aggregation confounds cell-based Covid-19 antiviral screens.
Glenn IS; Hall LN; Khalid MM; Ott M; Shoichet BK
bioRxiv; 2023 Oct; ():. PubMed ID: 37961552
[TBL] [Abstract][Full Text] [Related]
15. Author Correction: High-throughput screening of genetic and cellular drivers of syncytium formation induced by the spike protein of SARS-CoV-2.
Chan CWF; Wang B; Nan L; Huang X; Mao T; Chu HY; Luo C; Chu H; Choi GCG; Shum HC; Wong ASL
Nat Biomed Eng; 2024 Mar; 8(3):336. PubMed ID: 38267642
[No Abstract] [Full Text] [Related]
16. Identification of a druggable site on GRP78 at the GRP78-SARS-CoV-2 interface and virtual screening of compounds to disrupt that interface.
Lazou M; Hutton JR; Chakravarty A; Joseph-McCarthy D
J Comput Aided Mol Des; 2024 Jan; 38(1):6. PubMed ID: 38263499
[TBL] [Abstract][Full Text] [Related]
17. Structure based Drug Designing Approaches in SARS-CoV-2 Spike Inhibitor Design.
Shanmugam A; Venkattappan A; Gromiha MM
Curr Top Med Chem; 2022; 22(29):2396-2409. PubMed ID: 36330617
[TBL] [Abstract][Full Text] [Related]
18. Molecular screening of antimalarial, antiviral, anti-inflammatory and HIV protease inhibitors against spike glycoprotein of coronavirus.
Prashantha CN; Gouthami K; Lavanya L; Bhavanam S; Jakhar A; Shakthiraju RG; Suraj V; Sahana KV; Sujana HS; Guruprasad NM; Ramachandra R
J Mol Graph Model; 2021 Jan; 102():107769. PubMed ID: 33152616
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
